TNFSF15 and neoplasm: Recombinant TL1A triggered apoptosis in DR3-expressing tumor cell lines in combination with a protein synthesis inhibitor cycloheximide.34 Moreover, the injection of recombinant TL1A led to a much slower progression of mouse xenograft tumors derived from HT29-DR3 cells in a dose-dependent manner (Fig. 6e).